colorectal adenocarcinoma
Showing 1 - 25 of 7,800
Colorectal Adenocarcinoma Trial in Padova (Impact Oral®)
Not yet recruiting
- Colorectal Adenocarcinoma
- Impact Oral®
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 10, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Kaliningrad (Right hemicolectomy, Left hemicolectomy, Sigmoid colon
Recruiting
- Colorectal Cancer
- +5 more
- Right hemicolectomy
- +6 more
-
Kaliningrad, Kaliningrad Region, Russian FederationBaltic Federal University
Sep 15, 2023
Colorectal Cancer, Colorectal Polyp, Colorectal Adenoma Trial (MiWEndo System)
Not yet recruiting
- Colorectal Cancer
- +5 more
- MiWEndo System
- (no location specified)
Aug 9, 2023
Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR
Completed
- Metastatic Colorectal Adenocarcinoma
- (no location specified)
Oct 9, 2023
Colorectal Adenocarcinoma Trial in Wuhan (radiotherapy)
Recruiting
- Colorectal Adenocarcinoma
- radiotherapy
-
Wuhan, Hubei, ChinaMin Jin
Nov 22, 2022
Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial in
Recruiting
- Metastatic Colorectal Adenocarcinoma
- +6 more
- Biopsy
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Colorectal Tumors, Colorectal Tumors Malignant, Colorectal Tumors, Benign Trial (Robotic right hemicolectomy, Laparoscopic right
Not yet recruiting
- Colorectal Neoplasms
- +6 more
- Robotic right hemicolectomy
- Laparoscopic right hemicolectomy
- (no location specified)
Oct 2, 2023
Trifluridine/Tipiracil Plus Bevacizumab Versus
Completed
- Metastatic Colorectal Adenocarcinoma
-
Changsha, Hunan, ChinaHunan Cancer hospital
May 11, 2023
Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma
Not yet recruiting
- Advanced Colorectal Adenocarcinoma
- +5 more
- Balstilimab
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)
Recruiting
- EGFR NP_005219.2:p.S492R
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite
Completed
- Metastatic Colorectal Adenocarcinoma
- regorafenib plus anti-PD-1 antibodies
-
Changsha, Hunan, ChinaHunan Cancer hospital
Jul 4, 2023
Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- +2 more
- BET Bromodomain Inhibitor ZEN-3694
- +6 more
- (no location specified)
Oct 25, 2023
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With
Completed
- Metastatic Colorectal Adenocarcinoma
- Fruquintinib
- +3 more
-
Changsha, Hunan, ChinaHunan Cancer hospital
Sep 2, 2023
Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in
Recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Imiquimod
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Metastatic Colorectal Cancer, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Washington (Durvalumab, CV301,
Active, not recruiting
- Metastatic Colorectal Cancer
- +3 more
- Durvalumab
- +3 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center
Mar 15, 2022
Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)
Active, not recruiting
- Colorectal Cancer
- +4 more
- Durvalumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)
Not yet recruiting
- Appendiceal Adenocarcinoma
- Colorectal
- Circulating tumoral DNA directed neoadjuvant therapy arm
-
Houston, TexasM D Anderson Cancer Center
Jul 7, 2023
Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic Trial in Chicago (VS-6766, Cetuximab, Pill Diary)
Not yet recruiting
- Colorectal Cancer
- +4 more
- VS-6766
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Jan 6, 2022
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Recruiting
- Colorectal Neoplasms
- +5 more
-
Copenhagen, Capital Region Of Denmark, Denmark
- +8 more
Oct 13, 2023
Colorectal Adenocarcinoma, Colorectal Carcinoma Metastatic in the Lung, Stage IV Colorectal Cancer AJCC v8 Trial in Canada,
Recruiting
- Colorectal Adenocarcinoma
- +5 more
- Chemotherapy
- Metastasectomy
-
Boston, Massachusetts
- +7 more
Apr 19, 2022